Your browser doesn't support javascript.
loading
Exploration of an alternative reconstructed individual patient data-based approach for budget impact analysis of anticancer drugs.
Ma, Yue; Zhou, Jiting; Ye, Yuxin; Ma, Aixia; Li, Hongchao.
  • Ma Y; School of International Pharmaceutical Business, Jiangning District, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198, Jiangsu, China.
  • Zhou J; Center for Pharmacoeconomics and Outcomes Research of China Pharmaceutical University, Nanjing, 211198, Jiangsu, China.
  • Ye Y; School of International Pharmaceutical Business, Jiangning District, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198, Jiangsu, China.
  • Ma A; Center for Pharmacoeconomics and Outcomes Research of China Pharmaceutical University, Nanjing, 211198, Jiangsu, China.
  • Li H; School of International Pharmaceutical Business, Jiangning District, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198, Jiangsu, China.
Cost Eff Resour Alloc ; 21(1): 38, 2023 Jun 11.
Article en En | MEDLINE | ID: mdl-37303057
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Health_economic_evaluation Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Health_economic_evaluation Idioma: En Año: 2023 Tipo del documento: Article